Here's the live share price of Kopran along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Kopran has gained 17.00% CAGR. Over the past year, the corresponding return has been -48.06%.
Kopran’s current P/E of 24.62x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Kopran | 0.96 | 12.37 | -0.45 | -6.54 | -48.32 | 2.28 | 17.00 |
Sun Pharmaceutical Industries | 0.67 | -1.54 | -1.81 | -8.63 | -12.69 | 21.00 | 26.54 |
Divi's Laboratories | -0.23 | -3.36 | -8.06 | 2.15 | 12.36 | 18.35 | 13.97 |
Torrent Pharmaceuticals | 3.38 | -0.21 | 15.29 | 12.38 | 5.42 | 34.21 | 22.46 |
Cipla | -2.01 | -4.57 | 1.67 | 0.23 | -6.69 | 12.69 | 14.78 |
Dr. Reddy's Laboratories | -0.22 | 1.83 | -2.19 | 8.11 | -1.66 | 16.47 | 5.10 |
Mankind Pharma | -0.34 | 0.10 | 10.91 | 7.91 | -6.27 | 21.59 | 12.45 |
Zydus Lifesciences | 1.02 | 2.15 | 8.34 | 12.82 | -0.61 | 43.13 | 22.18 |
Lupin | -1.41 | 1.94 | 3.72 | -5.60 | -9.56 | 45.63 | 14.54 |
Alkem Laboratories | 1.66 | 2.79 | 15.81 | 10.16 | -7.94 | 19.54 | 15.21 |
Aurobindo Pharma | 1.17 | 3.91 | 0.46 | -8.30 | -26.20 | 28.93 | 7.27 |
Abbott India | -2.25 | -4.05 | -4.00 | -2.65 | 7.04 | 19.22 | 13.60 |
Glenmark Pharmaceuticals | -1.16 | 3.20 | 20.00 | 35.18 | 18.89 | 73.81 | 33.80 |
Laurus Labs | 1.91 | 4.30 | 36.03 | 46.06 | 93.73 | 21.27 | 27.22 |
Biocon | 1.61 | 0.04 | 3.21 | 3.08 | -4.04 | 8.22 | -3.20 |
GlaxoSmithKline Pharmaceuticals | 0.83 | -1.46 | -14.53 | -4.32 | 1.58 | 25.24 | 11.64 |
Anthem Biosciences | -4.92 | -2.60 | 12.42 | 12.42 | 12.42 | 3.98 | 2.37 |
Ipca Laboratories | 5.72 | -0.93 | 3.93 | -4.52 | -6.49 | 16.65 | 5.37 |
Cohance Lifesciences | -6.99 | 0.09 | -8.74 | -23.33 | -24.13 | 27.29 | 19.61 |
Gland Pharma | 1.31 | 3.71 | 14.01 | 24.91 | 8.58 | -2.13 | 2.04 |
Over the last one year, Kopran has declined 48.32% compared to peers like Sun Pharmaceutical Industries (-12.69%), Divi's Laboratories (12.36%), Torrent Pharmaceuticals (5.42%). From a 5 year perspective, Kopran has outperformed peers relative to Sun Pharmaceutical Industries (26.54%) and Divi's Laboratories (13.97%).
Day | SMA | EMA |
---|---|---|
5 | 174.99 | 174.04 |
10 | 178 | 174.31 |
20 | 170.13 | 172.23 |
50 | 168.91 | 171.8 |
100 | 178.01 | 177.22 |
200 | 185.29 | 191.39 |
In the latest quarter, Kopran saw a drop in promoter holding to 44.42%, while DII stake unchanged at 0.00%, FII holding fell to 0.76%, and public shareholding moved up to 54.81% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Motilal Oswal BSE Healthcare ETF | 648 | 0.03 | 0.01 |
Date Time | Announcement |
---|---|
Sep 18, 2025, 7:51 PM IST | Kopran Ltd - Announcement under Regulation 30 (LODR)-Change in Management |
Sep 11, 2025, 11:44 PM IST | Kopran Ltd - Shareholder Meeting / Postal Ballot-Outcome of AGM |
Sep 02, 2025, 7:40 PM IST | Kopran Ltd - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements |
Aug 16, 2025, 3:52 PM IST | Kopran Ltd - Reg. 34 (1) Annual Report. |
Aug 16, 2025, 3:22 PM IST | Kopran Ltd - Business Responsibility and Sustainability Reporting (BRSR) |
Kopran Ltd. is a Public Limited Listed company incorporated on 26/04/1958 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1958PLC011078 and registration number is 011078. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 271.01 Cr. and Equity Capital is Rs. 48.29 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Kopran is ₹178.00 as on Sep 23, 2025.
The Kopran is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Kopran is ₹859.48 Cr as on Sep 23, 2025.
Today’s highest and lowest price of Kopran are ₹180.15 and ₹171.10.
The 52-week high/low is the highest and lowest price at which Kopran stock has traded in the past 52-week or nearly a year. The 52-week high of Kopran is ₹357.35 and 52-week low of Kopran is ₹154.05 as on Sep 23, 2025.
The Kopran has shown returns of 3.25% over the past day, 12.37% for the past month, 1.22% over 3 months, -48.06% over 1 year, 2.28% across 3 years, and 17.0% over 5 years.
P/E ratio of and PB ratio of Kopran are 24.62 and 1.66 on Sep 23, 2025. While the company gives a dividend yield of 1.69 per annum.